BTAI News and Press, BioXcel Therapeutics Inc. From 03/01/24

NEW HAVEN, Conn., March 01, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its fourth quarter and full y...

2024-02-21 11:03:58 ET More on BioXcel Therapeutics BioXcel Therapeutics announces termination of proposed public offering BioXcel stock climbs on FDA fast track designation for prostate cancer therapy Seeking Alpha’s Quant Rating on BioXcel Therapeutics ...

PALM BEACH, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports project that the anal cancer market will continue its recent growth through 2030. An article on the MD Anderson website. It said: “More than 8,000 people in the U.S. are diag...

2024-02-13 12:42:27 ET DENVER, Colo., Feb. 13, 2024 ( www.247marketnews.com )- Today’s big trades include (NASDAQ:OMH), (AMEX:AULT), (NASDAQ:BMR), (NASDAQ:BGLC), (NASDAQ:BTAI), (NASDAQ:LIAN) Ohmyhome (NASDAQ: OMH ) is well below today’s $6.00 high, trading at $2.81...

2024-02-13 09:20:56 ET More on BioXcel Therapeutics BioXcel stock climbs on FDA fast track designation for prostate cancer therapy Seeking Alpha’s Quant Rating on BioXcel Therapeutics Historical earnings data for BioXcel Therapeutics Financial informat...

NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it has terminated its proposed public offering...

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 97.9% to $0.23 on volume of 419,200,402 shares Sunworks Inc. (SUNW) rose 87.9% to $0.1022 on volume of 385,386,904 shares Green Giant Inc. (GGE) rose 15.4% to $0.0427 on volume of 208,454,257 s...

2024-02-12 07:42:30 ET Read the full article on Seeking Alpha For further details see: BioXcel stock climbs on FDA fast track designation for prostate cancer therapy

Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on chemotherapy and no evidence of microsatellite instability BXCL701 is an investigational, oral innate immune activator designed to inflame the tumo...

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 121.6% to $0.2575 on volume of 398,287,485 shares Sunworks Inc. (SUNW) rose 116.6% to $0.11785 on volume of 366,627,028 shares Green Giant Inc. (GGE) rose 15.1% to $0.0426 on volume of 195,208,...